Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Berlinger brings a suite of proprietary and high-quality hardware and software solutions that broaden Sensitech's end-to-end cold chain monitoring product portfolio
Department presents a detailed overview of the Pharma and MediTechsector and gives a detailed presentation on the activities of Department
Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
Subscribe To Our Newsletter & Stay Updated
